Friday, May 14, 2021

Gene therapy from Biogen's $800M buyout flops in mid-stage study, dealing blow to new ambitions

Jason Mast. Editor. The #2 candidate from Biogen's $800 million ocular gene therapy buyout has failed in a mid-stage trial, ...
https://www.google.com/url?rct=j&sa=t&url=https://endpts.com/gene-therapy-from-biogens-800m-buyout-flops-in-mid-stage-study-dealing-blow-to-new-ambitions/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHGioJ9B7a6FkHihItrXf-KXZZEEA

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...